Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945333 · ClinicalTrials.gov registry record · NA
Personalized and Scalable Cognitive Remediation Approaches
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
- 5
- Study locations
NCT01945333 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 122 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT01945333, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive remediation
Study Locations (5)
New York
- Williamsburg Clinic - Brooklyn
- Institute for Community Living - Brooklyn
- Nyspi/ Cumc - New York
- The Bridge Inc - New York
- FEGS Bronx Mental Health Clinic - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01945333
The ClinicalTrials.gov registry entry for NCT01945333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive remediation is the first listed.
NCT01945333 reports 5 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01945333 about?
NCT01945333 is a clinical study titled "Personalized and Scalable Cognitive Remediation Approaches". The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement...
What is the current status of trial NCT01945333?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2013-09. Estimated completion is 2019-03-20.
What conditions does trial NCT01945333 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT01945333?
The interventions under investigation include: Cognitive remediation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01945333?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01945333 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.